Its observed impact on hormone receptor-related pathways, as indicated by the disparate findings in ERβ expression from western blot and PCR analyses, suggests that MTE might be explored for its modulatory effects on hormone-sensitive breast cancer subtypes. The gene discussed is ESR2; the disease is breast carcinoma.